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A. System Response Characteristics
It has been demonstrated in the literature that differences in the duration and strength of the activity
of the doubly phosphorylated extracellular signal-regulated kinase (ERK-PP), produced by the
mitogen activated protein kinase (MAPK) cascade considered in Section VI of the Main Text, may
generate distinct biological outcomes, such as cell differentiation, proliferation, and apoptosis.1–5
Experimental evidence suggests that immediate early gene (IEG) products function as sensors for
ERK-PP signal duration and strength.2,3 Moreover, it has been experimentally demonstrated that
the time-integrated ERK-PP response directly correlates with DNA synthesis.6,7
A conceptually simple way to explain these results is to assume the presence of a relatively
unstable IEG product C, which is phosphorylated by ERK-PP resulting in stable molecules C-P. If
we use the reaction
C+ERK-PP k→ C-P+ERK-PP
to model phosphorylation of C, then the concentration profile xC-P(t) of C-P will satisfy the follow-
ing differential equation:
dxC-P(t)
dt
= kxC(t)xERK-PP(t).
As a consequence,
xC-P(t)= kc
∫ t
0
xERK-PP(τ )dτ, for t ≥ 0,
where we assume for simplicity that the concentration of C remains constant for every t ≥ 0. This
shows that, at time t , the concentration of the stable phosphorylated product C-P will be propor-
tional to the cumulative concentration of ERK-PP within the time interval [0, t], in agreement with
previously published results.7
The concentration of C-P can induce distinct biological outcomes by influencing transcriptional
control. As a consequence, the integrated ERK-PP response is an important signalling character-
istic for sensitivity analysis. It has been observed however that, due to certain biochemical factors
(such as degradation and nuclear translocation), the integrated response of C-P may not be the only
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factor affecting cellular response. As a matter of fact, experimental evidence suggests that different
biological outcomes may be produced by an activated MAP kinase, such as ERK-PP, depending on
whether its concentration remains above a critical level for a sufficient period of time.1,6,8 There-
fore, the duration and strength of ERK-PP activity are two additional signaling characteristics of
importance to sensitivity analysis. Note however that Eq. (4) in the Main Text implies
I :=
∫ t
0
xERK-PP(τ )dτ = t0
[
1
t0
∫ t0
0
xERK-PP(τ )dτ
]
= D× S, for t ≥ t0,
which shows that the integrated response I , duration D, and strength S of ERK-PP depend on each
other. To avoid redundancy, we choose in this paper the duration and strength as two independent
signaling characteristics of interest to sensitivity analysis.
If T is the timing of the ERK-PP profile, then
∫ T
0 xERK-PP(τ )dτ =
∫ t0
T xERK-PP(τ )dτ [recall Eq. (4)
in the Main Text]. As a result,
xC-P(T )= x
max
C-P
2
,
where
xmaxC-P = κc
∫ t0
0
xERK-PP(τ )dτ
is the maximum attainable concentration of C-P. Therefore, T is the time required for the concen-
tration of C-P to reach its half maximum value. Smaller values of T indicate a fast response of C-P
activity to input stimuli, which may result in rapid activation of downstream transcriptional events
that can significantly influence cellular response. We therefore believe that the timing, as defined
by Eq. (4) in the Main Text, may be another important characteristic of the ERK-PP activity profile
that is relevant to sensitivity analysis.
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B. Derivative Approximation of Variances
If we assume that the response function R(u) is sufficiently smooth around 0, so that its derivatives
of order ≥ 3 at 0 are negligible, then its Taylor series expansion about 0 is given by
R(U )' R(0)+
J∑
j=1
∂R(0)
∂uj
Uj + 12
J∑
j=1
J∑
j ′=1
∂2 R(0)
∂uj∂uj ′
UjUj ′ . (1)
From Eq. (1) above, we obtain
E[R(U )]' R(0), (2)
Vj = Var[E[R(U ) |Uj ]]' λ2j
[
∂R(0)
∂uj
]2
, (3)
and
V = Var[R(U )]'
J∑
j=1
λ2j
[
∂R(0)
∂uj
]2
. (4)
To show Eqs. (2)–(4) above, we use Eq. (26) in the Main Text and the fact that the factors Uj are
statistically independent zero-mean Gaussian random variables with standard deviations λj . Recall
that, for a zero-mean Gaussian random variable Uj with standard deviation λj , we have that
E[U 3j ]= 0 and E[U 4j ]= 3λ4j .
Eq. (27) and Eq. (28) in the Main Text are now a consequence of Eq. (3) and Eq. (4) above.
Note that, if R(u) is linear, then Eqs. (2)–(4) above, and therefore Eq. (27) and Eq. (28) in
the Main Text, will be satisfied with equality, regardless of the statistical model assumed for the
factors Uj . More generally, Eq. (27) in the Main Text is satisfied with equality when R(u) is
additive. Indeed, if
R(u)=
J∑
j=1
Rj (uj ),
then
Vj = Var[E[R(U ) |Uj ]]= Var[R j (Uj )],
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and
V = Var[R(U )]=
J∑
j=1
Var[Rj (Uj )]=
J∑
j=1
Vj .
Since we take R(u) to be the logarithm of the timing, duration, or strength of the response
profile of a molecular species of interest, the requirement that R(u) is additive is less restrictive
than requiring one of these features to be additive. Indeed, we may have D(u)=∏Jj=1 exp{Dj (u j )}
for the duration, in which case R(u)= ln D(u)=∑Jj=1 Dj (u j ) and R(u) will be additive.
C. Monte Carlo Estimation
Let X and Y be two statistically independent random variables with probability density functions
fX(x) and fY (y), respectively, and Z = g(X,Y ) be another random variable, which is a function
of X and Y . The kth-order moment E
[
Z k
]
of Z is given by
E
[
Z k
]= ∫ ∞
−∞
∫ ∞
−∞
[g(x, y)]k fX(x) fY (y)dxdy.
We can derive a Monte Carlo estimator Ê
[
Z k
]
for this quantity by independently drawing samples
{x (l), l = 1,2, . . . , L} of X and {y(l), l = 1,2, . . . , L} of Y from the probability density functions
fX(x) and fY (y), respectively, and by setting
Ê
[
Z k
]= 1
L
L∑
l=1
[g(x (l), y(l))]k .
As a special case, we can estimate the mean and variance of Z by
Ê [Z ] = 1
L
L∑
l=1
g(x (l), y(l))
V̂ar [X ] = 1
L
L∑
l=1
g2(x (l), y(l))− Ê2 [Z ] ,
since Var[Z ]= E[Z2]−E2 [Z ].
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To derive a Monte Carlo estimator for the variance Var
[
E
[
g(X,Y ) | Y ]], note that
Var
[
E
[
g(X,Y ) | Y ]]
=
∫ ∞
−∞
E2
[
g(X,Y ) | Y ] fY (y)dy−{E[E[g(X,Y ) | Y ]]}2
=
∫ ∞
−∞
[∫ ∞
−∞
g(x1, y) fX(x1)dx1
][∫ ∞
−∞
g(x2, y) fX(x2)dx2
]
fY (y)dy−E2
[
g(X,Y )
]
=
∫ ∞
−∞
∫ ∞
−∞
∫ ∞
−∞
g(x1, y)g(x2, y) fX(x1) fX(x2) fY (y)dx1dx2dy−E2 [Z ] .
This leads to the following Monte Carlo estimator:
V̂ar
[
E
[
g(X,Y ) | Y ]]= 1
L
L∑
l=1
g(x (l)1 , y
(l))g(x (l)2 , y
(l))− Ê2 [Z ] ,
where {x (l)1 , l = 1,2, . . . , L}, {x (l)2 , l = 1,2, . . . , L} are two sets of samples of X drawn indepen-
dently from the probability density function fX(x), and {y(l), l = 1,2, . . . , L} is a set of samples
of Y drawn independently from the probability density function fY (y).
D. Sketch of Proof for Conditions C.1-C.7
In this section, we show that conditions C.1–C.7 are indeed satisfied by the Monte Carlo variance
estimators introduced in Section V of the Main Text.
Condition C.1 is a direct consequence of the fact that
V̂arj [R(U )]= 14L
{ L∑
l=1
[
R(u (l))− R(u (L+l))]2+ L∑
l=1
[
R(u (l)j )− R(u (l)( j))
]2}
, (5)
and
V̂arj j ′ [R(U )]= 14L
{ L∑
l=1
[
R(u (l)j )− R(u (l)( j))
]2+ L∑
l=1
[
R(u (l)j ′ )− R(u (l)( j ′))
]2}
. (6)
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Conditions C.2, C.3, C.5, and C.6 can be shown from Eq. (5) and Eq. (6) above, the fact that
V̂ar
[
E
[
R(U ) |Uj
]]= 1
2L
{ L∑
l=1
[
R(u (l))− R(u (l)( j))
][
R(u (l)j )− R(u (L+l))
]}
V̂ar
[
E
[
R(U ) |U ( j)
]]= 1
2L
{ L∑
l=1
[
R(u (l))− R(u (l)j )
][
R(u (l)( j))− R(u (L+l))
]}
V̂ar
[
E
[
R(U ) |Uj ,Uj ′
]]= 1
2L
{ L∑
l=1
[
R(u (l)j )− R(u (l)j ′ )
][
R(u (l)
( j ′))− R(u (l)( j))
]}
,
and the facts that fixing Uj implies that u (l) = u (l)( j) and u (L+l) = u (l)j , fixing U ( j) implies that
u (l) = u (l)j and u (L+l) = u (l)( j), whereas, fixing U ( j, j ′) implies that u (l)j = u (l)( j ′) and u (l)( j) = u (l)j ′ . To
show Condition C.4, we define
h1(l) := R(u (l))
h2(l) := R(u (L+l))
h3(l) := R(u (l)j )
h4(l) := R(u (l)( j)).
Then, by using some straightforward algebra, we can show that
{[h1(l)+h2(l)]− [h3(l)+h4(l)]}2 ≥ 0
implies
1
4
[
h21(l)+h22(l)+h23(l)+h24(l)
]
− 1
2
[h1(l)h2(l)+h3(l)h4(l)]
≥ 1
2
[h1(l)h3(l)+h2(l)h4(l)]− 12 [h1(l)h2(l)+h3(l)h4(l)]
+1
2
[h1(l)h4(l)+h2(l)h3(l)]− 12 [h1(l)h2(l)+h3(l)h4(l)] ,
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Figure 1: A biochemical reaction model of the MAPK signaling cascade.
which in turn implies that V̂arj [R(U )] ≥ V̂ar
[
E
[
R(U ) |Uj
]] + V̂ar[E[R(U ) |U ( j)]]. Condi-
tion C.7 can be shown similarly.
E. MAPK Signaling Cascade Model
In this section, we list the biochemical reactions associated with the MAPK signaling cascade
model we consider in the Main Text and provide nominal values for the reaction rate constants and
values for the initial molecular activities. We depict this model in Fig. 1, whereas, in Fig. 2, we
depict the activity profiles of selected species. We have adopted the data from Schoeberl et al.,9
with a few rate constant values updated from the ‘JWS Online Cellular Systems Modeling’ web
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Figure 2: Activity profiles of: (a) Ras-GTP, (b) Raf*, (c) MEK-PP, and (d) ERK-PP, predicted by
the MAPK cascade model depicted in Fig. 1.
site (http://jjj.biochem.sun.ac.za). The first reaction in the model depicted in Fig. 1 compensates
for Ras-GTP synthesis, which, in reality, is accomplished by a complex epidermal growth factor
(EGF)-induced signalling pathway.9 We have set the reaction rate constant of Ras-GTP synthesis
equal to 3s−1. This value results in an ERK-PP activity profile that is similar to the one reported
by Schoeberl et al.,9 with 50ng/ml EGF; compare Fig. 2(d) with Fig. 2(F) in Schoeberl et al.9
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Reactions
No. Reaction Rate Constant (s−1)
1 ∅ → Ras-GTP κ1 = 3
Ras-GTP→ ∅ κ2 = 0
2 Ras-GTP + Raf→ Raf-Ras-GTP κ3 = 1.6605×10−6
Raf-Ras-GTP→ Raf + Ras-GTP κ4 = 5.3×10−3
3 Raf-Ras-GTP→ Raf* + Ras-GTP* κ5 = 1
Raf* + Ras-GTP*→ Raf-Ras-GTP κ6 = 1.1624×10−6
4 Raf* + Pho1→ Raf*-Pho1 κ7 = 1.1790×10−4
Raf*-Pho1→ Raf* + Pho1 κ8 = 0.2
5 Raf*-Pho1→ Raf + Pho1 κ9 = 1
Raf + Pho1→ Raf*-Pho1 κ10 = 0
6 MEK + Raf*→MEK-Raf* κ11 = 1.9428×10−5
MEK-Raf*→MEK + Raf* κ12 = 3.3×10−2
7 MEK-Raf*→MEK-P + Raf* κ13 = 3.5
MEK-P + Raf*→MEK-Raf* κ14 = 0
8 MEK-P + Raf*→MEK-P-Raf* κ15 = 1.9428×10−5
MEK-P-Raf*→MEK-P + Raf* κ16 = 3.3×10−2
9 MEK-P-Raf*→MEK-PP + Raf* κ17 = 2.9
MEK-PP + Raf*→MEK-P-Raf* κ18 = 0
10 MEK-PP + Pho2→MEK-PP-Pho2 κ19 = 2.3746×10−5
MEK-PP-Pho2→MEK-PP + Pho2 κ20 = 0.8
11 MEK-PP-Pho2→MEK-P + Pho2 κ21 = 5.8×10−2
MEK-P + Pho2→MEK-PP-Pho2 κ22 = 0
12 MEK-P + Pho2→MEK-P-Pho2 κ23 = 4.4835×10−7
MEK-P-Pho2→MEK-P + Pho2 κ24 = 0.5
13 MEK-P-Pho2→MEK + Pho2 κ25 = 5.8×10−2
MEK + Pho2→MEK-P-Pho2 κ26 = 0
14 ERK + MEK-PP→ ERK-MEK-PP κ27 = 8.8673×10−5
ERK-MEK-PP→ ERK + MEK-PP κ28 = 1.833×10−2
15 ERK-MEK-PP→ ERK-P + MEK-PP κ29 = 16
ERK-P + MEK-PP→ ERK-MEK-PP κ30 = 0
16 ERK-P + MEK-PP→ ERK-P-MEK-PP κ31 = 8.8673×10−5
ERK-P-MEK-PP→ ERK-P + MEK-PP κ32 = 1.833×10−2
17 ERK-P-MEK-PP→ ERK-PP + MEK-PP κ33 = 5.7
ERK-PP + MEK-PP→ ERK-P-MEK-PP κ34 = 0
18 ERK-PP + Pho3→ ERK-PP-Pho3 κ35 = 2.3414×10−5
ERK-PP-Pho3→ ERK-PP + Pho3 κ36 = 0.6
19 ERK-PP-Pho3→ ERK-P + Pho3 κ37 = 0.246
ERK-P + Pho3→ ERK-PP-Pho3 κ38 = 0
20 ERK-P + Pho3→ ERK-P-Pho3 κ39 = 8.3027×10−6
ERK-P-Pho3→ ERK-P + Pho3 κ40 = 0.5
21 ERK + Pho3→ ERK-P-Pho3 κ41 = 0
ERK-P-Pho3→ ERK + Pho3 κ42 = 0.246
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Initial Conditions
No. species molecules/cell
1 Ras-GTP 7.20×104
2 Raf 4.00×104
3 Raf-Ras-GTP 0
4 Raf* 0
5 Pho1 4.00×104
6 Raf*-Pho1 0
7 MEK 2.10×108
8 MEK-Raf* 0
9 MEK-P 0
10 MEK-P-Raf* 0
11 MEK-PP 0
12 Pho2 4.00×104
13 MEK-PP-Pho2 0
14 MEK-P-Pho2 0
15 ERK 2.21×107
16 ERK-MEK-PP 0
17 ERK-P 0
18 ERK-P-MEK-PP 0
19 ERK-PP 0
20 Pho3 1.00×107
21 ERK-PP-Pho3 0
22 ERK-P-Pho3 0
23 Ras-GTP* 0
To use the previous reaction rate values, we must check whether these values satisfy Eq. (8) in
the Main Text. In particular, we need to show that there exist capacities c‡m , m = 1,2, . . . ,M , and
cn , n = 1,2, . . . ,N , so that Eq. (8) in the Main Text is satisfied. Note that
κ2m−1
κ2m
=
N∏
n=1
csnmn , for every m ∈Mr , (7)
from Eq. (19) in the Main Text, where snm is given by Eq. (3) in the Main Text andMr denotes the
set of all reversible reactions in the MAPK cascade (i.e., reactions 2–4, 6, 8, 10, 12, 14, 16, 18, and
20). If we denote by Sr the N ×Mr stoichiometry matrix associated with the reversible reactions,
by c the N × 1 vector of the molecular capacities cn,n = 1,2, . . . ,N , and by r the Mr × 1 vector
of the reaction rate ratios κ2m−1/κ2m , m ∈Mr , then we can write Eq. (7) above in the following
matrix-vector form:
STr lnc = lnr ,
where lnu denotes a vector with elements lnui , where ui is the i th element of vector u .
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It turns out that, for the MAPK cascade, the columns of the stoichiometry matrix Sr are linearly
independent; i.e., rank(Sr )= Mr . As a consequence, we can write
STr lnc =
 S∗
S∗∗

T  lnc1
lnc2
= ST∗ lnc1+ST∗∗ lnc2 = lnr , (8)
where S∗ is the Mr × Mr matrix that contains all linearly independent rows of Sr , S∗∗ is the
(N −Mr )×Mr matrix that contains the remaining rows of Sr , and c1, c2 are the corresponding
subvectors of c. Note that S∗ is an invertible matrix. Therefore, Eq. (8) above implies that
lnc1 = (ST∗)−1
(
lnr −ST∗∗ lnc2
)
.
We can now set lnc2 = 0, in which case lnc1 = (ST∗)−1 lnr . Therefore, given the reaction rate
constants of the reversible reactions, we can find capacity values for all molecular species in the
system. Subsequently, we can determine the capacities of the activated complexes by setting
c‡m = κ2m−1
h
kB T
N∏
n=1
cνnmn , for m = 1,2, . . . ,M .
The previous discussion shows that the rate constant values we are using in this paper corre-
spond to a thermodynamically feasible model for the MAPK cascade, since, given these values, we
can find appropriate capacity values so that the Eyring-Polanyi equations are satisfied. Although
we could use the previous steps to calculate the actual capacity values, we do not do that here since
these values are immaterial for sensitivity analysis.
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